Lilly Immergluck to Middle Aged
This is a "connection" page, showing publications Lilly Immergluck has written about Middle Aged.
Connection Strength
0.032
-
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 Feb 05; 80(1):223-227.
Score: 0.016
-
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost. Nat Commun. 2025 Jan 17; 16(1):759.
Score: 0.016